CD8A and glioblastoma: The screen hits, including PDIA3, MGAT5, EMP1, and LAG3 gene editing, were validated through the adoptive transfer of CD8 + T cells, enhancing the survival of GBM-bearing mice in both syngeneic and T cell receptor transgenic models [47].